Market Challenges – Product recalls

Increasing number of products recalls due to product failure, component inconsistency, and packaging problems is expected to hamper the growth of the global advanced wound care management market. For instance, in March 2022, BlaineLabs, a drug and medical device manufacturing company, announced that it had recalled a single lot of RevitaDerm Wound Care Gel (benzalkonium chloride gel containing transforming growth factor beta).

Market Opportunities – Emerging solutions for advanced wound care management

The development of new solutions for the management of burns and wounds is expected to hold huge potential for growth of global advanced wound care management market over the forecast period. For instance, in October 2021, Solascure Limited, a U.K.-based biotechnology company that focuses on the development of advanced wound care products, announced that it had initiated clinical trials for Aurase Wound Gel, its investigational wound cleaning product.

Advanced Wound Care Management Market Report Snapshots